Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Keith D. Salazar, Carey B. Copeland, Charles E. Wood, Judith E. Schmid & Robert W. Luebke. (2013) Evaluation of anti-nuclear antibodies and kidney pathology in Lewis rats following exposure to Libby amphibole asbestos. Journal of Immunotoxicology 10:4, pages 329-333.
Read now
Read now
Kunio Takada, Kimihiro Suzuki, Mitsuyo Matsumoto, Makoto Okada, Takashi Nakanishi, Hideyuki Horikoshi, Tomoaki Higuchi, Akiyoshi Nakayama & Fumitaka Ohsuzu. (2008) The relationships between titers of anti-Ro or anti-La as measured by ELISA and salivary production rate with age correction. Modern Rheumatology 18:6, pages 578-584.
Read now
Read now
Trinh T. Tran & David S. Pisetsky. (2004) Systemic Lupus Erythematosus and Related Diseases. Autoimmunity 37:4, pages 301-304.
Read now
Read now
Articles from other publishers (29)
May Yee Choi, Ann Elaine Clarke, Murray Urowitz, John Hanly, Yvan St-Pierre, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Sasha Bernatsky, Daniel J Wallace, David Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcón, Ronald F van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sam Lim, Murat Inanc, Ken Kalunian, Søren Jacobsen, Christine Peschken, Diane L Kamen, Anca Askanase, Jill P Buyon, Karen H Costenbader & Marvin J Fritzler. (2022) Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. Annals of the Rheumatic Diseases 81:8, pages 1143-1150.
Crossref
Crossref
Ioannis Parodis, Emil Åkerström, Christopher Sjöwall, Azita Sohrabian, Andreas Jönsen, Alvaro Gomez, Martina Frodlund, Agneta Zickert, Anders A Bengtsson, Johan Rönnelid & Iva Gunnarsson. (2020) Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus. International Journal of Molecular Sciences 21:10, pages 3463.
Crossref
Crossref
M Frodlund, J Wetterö, C Dahle, Ö Dahlström, T Skogh, J Rönnelid & C Sjöwall. (2020) Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease. Clinical & Experimental Immunology 199:3, pages 245-254.
Crossref
Crossref
Jorge I. Ramírez Sepúlveda, Karin Bolin, Johannes Mofors, Dag Leonard, Elisabet Svenungsson, Andreas Jönsen, Christine Bengtsson, Gunnel Nordmark, Solbritt Rantapää Dahlqvist, Anders A. Bengtsson, Lars Rönnblom, Christopher Sjöwall, Iva Gunnarsson & Marie Wahren-Herlenius. (2019) Sex differences in clinical presentation of systemic lupus erythematosus. Biology of Sex Differences 10:1.
Crossref
Crossref
Augusto Juste-Dolz, Noelle M. do Nascimento, Isidro Monzó, Elena Grau-García, Jose A. Román-Ivorra, José Luis Lopez-Paz, Jorge Escorihuela, Rosa Puchades, Sergi Morais, David Gimenez-Romero & Ángel Maquieira. (2018) New structural insights into the role of TROVE2 complexes in the on-set and pathogenesis of systemic lupus erythematosus determined by a combination of QCM-D and DPI. Analytical and Bioanalytical Chemistry 411:19, pages 4709-4720.
Crossref
Crossref
Jorge I. Ramírez Sepúlveda, Marika Kvarnström, Susanna Brauner, Chiara Baldini & Marie Wahren-Herlenius. (2017) Difference in clinical presentation between women and men in incident primary Sjögren’s syndrome. Biology of Sex Differences 8:1.
Crossref
Crossref
David S. Pisetsky, Brad H. Rovin & Peter E. Lipsky. (2017) New Perspectives in Rheumatology: Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of Antinuclear Antibodies and Anti-DNA. Arthritis & Rheumatology 69:3, pages 487-493.
Crossref
Crossref
J W Lee, D J Park, J H Kang, S E Choi, Y R Yim, J E Kim, K E Lee, L Wen, T J Kim, Y W Park, Y K Sung & S S Lee. (2016) The rate of and risk factors for frequent hospitalization in systemic lupus erythematosus: results from the Korean lupus network registry. Lupus 25:13, pages 1412-1419.
Crossref
Crossref
K. Kerboua, S. Chaib & F. Haiba. (2016) Association between anti-Ro 60kDa (SS-A) autoantibodies and hypocomplementemia in systemic lupus erythematosus patients from Algiers prefectures. The Egyptian Rheumatologist 38:3, pages 171-176.
Crossref
Crossref
A. S. Nasr, S. M. Fawzy, T. A. Gheita & E. El-Khateeb. (2015) Expression of Toll?like receptors?3 and?9 in Egyptian systemic lupus erythematosus patientsExpression der Toll?like?Rezeptoren?3 und 9 bei ?gyptischen Patienten mit systemischem Lupus?erythematodes. Zeitschrift f?r Rheumatologie 75:5, pages 502-507.
Crossref
Crossref
David S. Pisetsky. (2015) Anti-DNA antibodies — quintessential biomarkers of SLE. Nature Reviews Rheumatology 12:2, pages 102-110.
Crossref
Crossref
Emanuele Cozzani, Massimo Drosera, Giulia Gasparini & Aurora Parodi. (2014) Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical Aspects. Autoimmune Diseases 2014, pages 1-13.
Crossref
Crossref
Yu-Jih Su, Tien-Tsai Cheng, Chung-Jen Chen, Wen-Chan Chiu, Chung-Yuan Hsu, Wen-Neng Chang, Nai-Wen Tsai, Chia-Te Kung, Hung-Chen Wang, Wei-Che Lin, Chih-Cheng Huang, Ya-Ting Chang, Chih-Min Su, Yi-Fang Chiang, Ben-Chung Cheng, Yu-Jun Lin & Cheng-Hsien Lu. (2013) The association among leukocyte apoptosis, autoantibodies and disease severity in systemic lupus erythematosus. Journal of Translational Medicine 11:1.
Crossref
Crossref
Leishangthem Bidyalaxmi Devi, Archana Bhatnagar, Ajay Wanchu & Aman Sharma. (2013) A study on the association of autoantibodies, chemokine, and its receptor with disease activity in systemic lupus erythematosus in North Indian population. Rheumatology International 33:11, pages 2819-2826.
Crossref
Crossref
E Åhlin, L Mathsson, M-L Eloranta, T Jonsdottir, I Gunnarsson, L Rönnblom & J Rönnelid. (2012) Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE. Lupus 21:6, pages 586-595.
Crossref
Crossref
Ryusuke Yoshimi, Atsuhisa Ueda, Keiko Ozato & Yoshiaki Ishigatsubo. (2012) Clinical and Pathological Roles of Ro/SSA Autoantibody System. Clinical and Developmental Immunology 2012, pages 1-12.
Crossref
Crossref
L Strandberg, O Winqvist, S-E Sonesson, S Mohseni, S Salomonsson, K Bremme, J P Buyon, H Julkunen & M Wahren-Herlenius. (2008) Antibodies to amino acid 200–239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block. Clinical and Experimental Immunology 154:1, pages 30-37.
Crossref
Crossref
David J. Blake, Scott A. Wetzel & Jean C. Pfau. (2008) Autoantibodies from mice exposed to Libby amphibole asbestos bind SSA/Ro52-enriched apoptotic blebs of murine macrophages. Toxicology 246:2-3, pages 172-179.
Crossref
Crossref
Johan Rönnelid*Erik Åhlin, Bo Nilsson, Kristina Nilsson-Ekdahl & Linda Mathsson. 2008. Current Topics in Complement II. Current Topics in Complement II
180
194
.
L Mathsson, E Åhlin, C Sjöwall, T Skogh & J Rönnelid. (2007)
Cytokine induction by circulating immune complexes and signs of
in-vivo
complement activation in systemic lupus erythematosus are associated with the occurrence of anti-Sjögren's syndrome A antibodies
. Clinical and Experimental Immunology 147:3, pages 513-520.
Crossref
Crossref
K Popovic, S Brauner, M Ek, M Wahren-Herlenius & F Nyberg. (2016) Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun. Lupus 16:1, pages 10-17.
Crossref
Crossref
Karin Popovic, Fredrik Nyberg, Marie Wahren-Herlenius & Filippa Nyberg. (2007) A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus. Arthritis & Rheumatism 56:1, pages 255-264.
Crossref
Crossref
Jennifer A. Croker & Robert P. Kimberly. (2005) SLE: challenges and candidates in human disease. Trends in Immunology 26:11, pages 580-586.
Crossref
Crossref
D. Villalta, N. Bizzaro, S. Platzgummer, A. Antico, M. Tampoia, L. Camogliano, D. Bassetti, M. Pradella, A. Piazza, F. Manoni, R. Tozzoli & E. Tonutti. (2004) Accuracy of semiquantitative immunoenzymatic methods in quantitation of anti-topoisomerase I (Scl-70) antibodies. Clinical Rheumatology 24:5, pages 453-459.
Crossref
Crossref
Robert M. Clancy, Jill P. Buyon, Keigo Ikeda, Kazuhisa Nozawa, Dionne A. Argyle, Deborah M. Friedman & Edward K. L. Chan. (2005) Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects. Arthritis & Rheumatism 52:10, pages 3079-3086.
Crossref
Crossref
Henning Locht, Randi Pelck & Rolf Manthorpe. (2005) Clinical manifestations correlated to the prevalence of autoantibodies in a large (n=321) cohort of patients with primary Sjögren's syndrome. Autoimmunity Reviews 4:5, pages 276-281.
Crossref
Crossref
J D Reveille. (2016) Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus 13:5, pages 290-297.
Crossref
Crossref
Natalia Saccodossi, Rosa B. Cabrera, Fernando Oliver, Lucila Gelmi, Daniel G. Magglio, Héctor M. Fernández-Lahore, Juliana Leoni & Rita R. Stumpo. (2004) Chemical extraction and direct adsorptive purification of recombinant human antigen Ro52. Journal of Separation Science 27:7-8, pages 589-594.
Crossref
Crossref
Dooil Jeoung, Yoon Lim, Eun Bong Lee, Seongeun Lee, Hae-Yeong Kim, Hansoo Lee & Yeong Wook Song. (2004) Identification of autoantibody against poly (ADP-ribose) polymerase (PARP) fragment as a serological marker in systemic lupus erythematosus. Journal of Autoimmunity 22:1, pages 87-94.
Crossref
Crossref